Hochschulschrift
Role of prostanoid receptor EP1 in the progression of non-small cell lung cancer (NSCLC)
- Weitere Titel
-
Die Rolle des Prostanoid-Rezeptors EP1 bei der Progression des nicht-kleinzelligen Lungenkarzinoms (NSCLC)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Gießen, Justus-Liebig-Universität, Diss., 2013
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Gießen
- (wer)
-
Universitätsbibliothek
- (wann)
-
2013
- Urheber
- URN
-
urn:nbn:de:hebis:26-opus-94987
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Pamarthi, Pavan Kumar
- Universitätsbibliothek
Entstanden
- 2013
Ähnliche Objekte (12)
Role of prostanoid receptor EP1 in the progression of non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
Chronic stress promotes non-small cell lung cancer (NSCLC) progression through circMBOAT2 upregulation mediated by CTCF
ASCO 2020 non-small lung cancer (NSCLC) personal highlights
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
Doxycycline inhibits electric field-induced migration of non-small cell lung cancer (NSCLC) cells
Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective
Role of prostanoid receptor EP1 in the progression of non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
Chronic stress promotes non-small cell lung cancer (NSCLC) progression through circMBOAT2 upregulation mediated by CTCF
ASCO 2020 non-small lung cancer (NSCLC) personal highlights
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
Doxycycline inhibits electric field-induced migration of non-small cell lung cancer (NSCLC) cells
Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective
Role of prostanoid receptor EP1 in the progression of non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
Chronic stress promotes non-small cell lung cancer (NSCLC) progression through circMBOAT2 upregulation mediated by CTCF
ASCO 2020 non-small lung cancer (NSCLC) personal highlights
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
Doxycycline inhibits electric field-induced migration of non-small cell lung cancer (NSCLC) cells